AI Stock Picks — S&P 500

Wednesday, July 22, 2026  ·  Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days

Today's Market Mood

Optimistic  Normal choppiness · VIX 16.8

Breadth is recovering from a sharp broad-based drawdown -- most S&P 500 names still sit far below their 52-week highs, but a wide set of stocks across energy, financials, insurance, healthcare and REITs are showing strong, sustained 5-day and 30-day upside momentum and are trading within a few percent of new highs. Energy refiners and midstream names are leading on strong crack spreads/commodity strength, while banks, insurers and defensive healthcare/staples are also confirming the bounce with multi-week follow-through rather than one-day spikes.

Energy refiners and midstream (MPC, VLO, PSX, TRGP) posting the strongest 30-day gains near 52-week highsFinancials and insurers (JPM, BAC, USB, TRV, ALL, MET, PRU) confirming steady multi-week strength near highsHealthcare/pharma (ABBV, MRK, VTRS, INCY, DOC, CVS) showing durable rebounds with limited distance from highsResidential/retail REITs (WELL, VTR, KIM, FRT) extending gains within 1-2% of 52-week highsBroader market breadth still recovering -- most tech/semis remain deeply below highs despite short-term bounces, favoring value/cyclical over growth for near-term continuation
Behind the scenes: how each AI analyst did
Aria
7 picks
Blaze
9 picks
Nova
3 picks
Orion
6 picks
Quinn
8 picks

5 Stock Picks

#1 VTRVentas, Inc.
5/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals
Strong conviction · 74%

Ventas owns senior living communities and other healthcare real estate, benefiting from the aging Baby Boomer population needing housing. The company just raised its full-year profit guidance on the back of strong occupancy gains, and insiders have been net buyers of the stock recently. The main risk is that real estate stocks are sensitive to interest rate changes, and shares have already climbed nearly 17% in a month.

Stop-loss$90.14-7.2%
Today's price$97.14
Target$101.99+5.0%
If you invested $1,000
▲$1,050 if the target hits (+5.0%)
▼$928 if the stop-loss is hit (-7.2%)
The AI puts the chance of the win case at 74%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • Price is already at the upper Bollinger Band (97.14 vs. band of 98.34) with RSI(14) at 70.87, leaving little room before a mean-reversion pullback given the 5-day momentum (5.01%) is decelerating relative to the full 30-day move (16.97%).
  • The stock's own 20-day-average volume (626,385 shares) is thin for a name that just gained 17% in a month, meaning any profit-taking after such a sharp move could produce an outsized reversal on relatively light liquidity.
Show the detailed analysis

Calibrated probability: 74% (raw model estimate: 63%) — adjusted using the accuracy of past resolved picks.

Trade math

0.7:1
59%
+0.5%
10%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice.

What each AI analyst estimated

Aria
65%
High
Blaze
74%
Very High
Nova
56%
Medium
Orion
61%
High
Quinn
60%
Medium

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha
#2 TRGPTarga Resources Corp.
3/5 Agents Agree  Risk 4/10
Strong conviction · 74%

Targa Resources gathers, processes and transports natural gas and natural gas liquids across the US. Its stock hasn't run up as much as some other energy names yet, which may leave room for further gains as energy prices stay strong, and its technical indicators look healthy. The main risks are a pullback in the current momentum and an earnings report in the coming weeks that could move the stock sharply.

Stop-loss$257.79-8.9%
Today's price$282.98
Target$297.12+5.0%
If you invested $1,000
▲$1,050 if the target hits (+5.0%)
▼$911 if the stop-loss is hit (-8.9%)
The AI puts the chance of the win case at 74%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • MACD histogram (0.7424) is already the widest of the five picks even though RSI (60.86) is framed as 'room to run' — a widening histogram this late in a 6.98% 30-day advance often precedes histogram contraction (momentum peak) rather than further acceleration.
  • 5-day momentum has already slowed to 1.67% versus the 6.97% 30-day return, and price is only 1.14% below the upper Bollinger Band (282.98 vs. 288.93) — the 'more room to run' argument understates how compressed the remaining technical runway actually is.
Show the detailed analysis

Calibrated probability: 74% (raw model estimate: 69%) — adjusted using the accuracy of past resolved picks.

Trade math

0.6:1
64%
+0.7%
10%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice.

What each AI analyst estimated

Aria
75%
Very High
Blaze
66%
High
Nova
—
—
Orion
66%
High
Quinn
—
—

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha
#3 PRUPrudential Financial, Inc.
3/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals
Strong conviction · 74%

Prudential Financial sells life insurance, retirement plans and investment products. Its stock has been rising steadily and is beating the broader market, with healthy technical signals suggesting more room to run. The main risk is a broad market or interest-rate driven reversal, especially since some company insiders have been selling shares.

Stop-loss$112.34-5.5%
Today's price$118.88
Target$124.82+5.0%
If you invested $1,000
▲$1,050 if the target hits (+5.0%)
▼$945 if the stop-loss is hit (-5.5%)
The AI puts the chance of the win case at 74%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • Price at 118.88 is within 2.5% of the upper Bollinger Band (121.82), and the MACD histogram is thin and narrowing (0.2211, with MACD line 3.2892 barely above signal 3.0681) — a much weaker crossover cushion than the other picks, suggesting the bullish crossover could invert quickly.
  • SMA50 (107.89) and SMA200 (105.08) are close together, indicating the longer-term trend was flat before this 30-day spike — the 9.81% move looks like a sharp break from a rangebound base rather than continuation of an established uptrend.
Show the detailed analysis

Calibrated probability: 74% (raw model estimate: 64%) — adjusted using the accuracy of past resolved picks.

Trade math

0.9:1
52%
+1.2%
10%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice.

What each AI analyst estimated

Aria
75%
Very High
Blaze
—
—
Nova
—
—
Orion
58%
Medium
Quinn
60%
Medium

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha
#4 CVSCVS Health Corporation
2/5 Agents Agree  Risk 3/10
Very strong conviction · 78%

CVS Health runs pharmacies, a health insurance business, and retail stores across the country. The stock has been recovering strongly and is beating the market, with volume trends supporting the move higher. The main risks are an upcoming earnings report, a large insider stock sale earlier this year, and the chance the rally cools off.

Stop-loss$101.44-7.3%
Today's price$109.43
Target$114.90+5.0%
If you invested $1,000
▲$1,050 if the target hits (+5.0%)
▼$927 if the stop-loss is hit (-7.3%)
The AI puts the chance of the win case at 78%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • Only 2 of 5 agents agreed on CVS, and its RSI at 69.23 sits at essentially the same overbought level as VTR (70.87) and PRU (69.04) — both of which needed a full 5-agent or majority consensus, while CVS reached a 70% probability with far thinner agreement, warranting more skepticism of the edge.
  • The MACD histogram (0.1342) is the smallest of all five candidates and price (109.43) is barely below the upper Bollinger Band (109.68), leaving almost no technical cushion for the 'more room to run' case.
Show the detailed analysis

Calibrated probability: 78% (raw model estimate: 70%) — adjusted using the accuracy of past resolved picks.

Trade math

0.7:1
59%
+1.3%
10%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice.

What each AI analyst estimated

Aria
75%
Very High
Blaze
66%
High
Nova
—
—
Positive trend but weaker 5-day momentum than the selected picks and no specific catalyst identified
Orion
—
—
A large insider sold over $300 million in stock recently, and earnings fall inside the 30-day window
Quinn
—
—

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha
#5 MRKMerck & Co., Inc.
2/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals
Strong conviction · 74%

Merck is a major drugmaker best known for its cancer treatment Keytruda. The company just raised its full-year profit forecast and used confident language about its growth pipeline, and the stock's technical picture (RSI in the high 50s) shows it isn't overheated despite a solid month-long rally. The main risk is that a large recent acquisition charge muddies the headline numbers, and the stock could stall if the broader market pulls back.

Stop-loss$116.55-9.0%
Today's price$128.08
Target$134.48+5.0%
If you invested $1,000
▲$1,050 if the target hits (+5.0%)
▼$910 if the stop-loss is hit (-9.0%)
The AI puts the chance of the win case at 74%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • OBV divergence is flagged true and the MACD histogram is negative (-0.1213, MACD line 1.6717 below signal 1.7930) — both indicate volume/momentum are turning down even as price stays elevated, directly undercutting the 'healthy, not overbought' technical framing.
  • 5-day momentum (2.75%) has already decelerated well below the 30-day pace (11.02%), consistent with the MACD's bearish crossover rather than continued upside.
Show the detailed analysis

Calibrated probability: 74% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.

Trade math

0.6:1
64%
+0.2%
10%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice.

What each AI analyst estimated

Aria
—
—
Blaze
74%
Very High
Nova
—
—
Orion
58%
Medium
Quinn
—
—
MACD histogram is negative and OBV shows a bearish divergence — price is rising without full volume confirmation.

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha

Retail Investor Execution Guide

This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by August 21, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.

Step-by-Step Action Plan

  1. Act within one trading day. Prices are freshest now. The longer you wait, the more the entry price drifts away from what the agents analysed.
  2. Verify the entry price. Check the live price before buying. If a stock has already moved more than 3% above the Current Price shown in the report, skip it or wait for a pullback — the risk/reward has shifted.
  3. Use limit orders, not market orders. Set your buy limit at or below the Current Price shown. Chasing with a market order gives brokers and algorithms an advantage over you.
  4. Set your stop-loss immediately after buying. Use the Max Downside % on each pick card as your hard exit level. If the price falls to that level, sell without hesitation — the trade thesis is broken.
  5. Set a take-profit at the Target Price. Place a limit sell order at the Target Price shown. When it fills, the trade is done — resist the urge to hold for more.
  6. Exit all positions by August 21, 2026. This is your hard deadline. If a stock has not hit its target by then, exit anyway. Holding past the window turns a short-term trade into an unsupervised long-term position.
  7. Never add to a losing position. If your stop-loss is hit, exit completely. Averaging down turns a small, controlled loss into a potentially large one.

Position Sizing by Conviction Tier

Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.

Agents Agreeing What It Means Max Allocation Per Pick
5/5 Highest conviction — all five independent analytical checks passed Up to 10%
4/5 Very high conviction — four of five independent checks aligned Up to 8%
3/5 High conviction — three agents independently agreed Up to 6%
2/5 Moderate conviction — two agents independently agreed Up to 4%
1 Agent Speculative — solo pick, admitted only at Very High confidence Up to 2%

The Three Exit Rules

These picks are generated by AI agents for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Probability estimates reflect the agents' analytical models — they are not guarantees of any outcome. Past results are not indicative of future performance. Markets can and do move against even well-researched trades. Always conduct your own research, and consider seeking advice from a licensed financial adviser before placing any orders. Never invest money you cannot afford to lose.

Understanding the Numbers

A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.

AI Conviction Meter
Estimated probability of hitting the target, shown as a 5-bar gauge
The filled bars and label translate the AI's probability estimate into plain language: 75%+ is Very strong, 60–74% Strong, 50–59% Moderate, below 50% Cautious. Where enough past picks have been resolved, the probability is calibrated against the AI's real track record.
e.g. "Moderate conviction · 58%" — the AI thinks this trade works slightly more often than a coin flip.
✓ More filled bars = more confidence — but even Very strong picks fail sometimes; always size positions accordingly.
If You Invested $1,000
$1,000 × (1 + Target Gain ÷ 100)  /  $1,000 × (1 + Max Downside ÷ 100)
The same Target Gain and Max Downside percentages expressed in concrete money terms for a $1,000 position — what you'd have if the target hits versus if your stop-loss is triggered.
e.g. +10% target and −12.3% stop → $1,100 on a win, $877 on a stopped-out loss.
✓ Scales linearly — a $500 position sees half these amounts, a $2,000 position double.
Current Price
Market price at time of analysis
The stock's price when this report was generated. All other figures on the card are calculated from this reference point.
e.g. $215.20 — check the live price before placing an order; if it has moved more than ~3%, re-evaluate the risk/reward.
✓ No positive/negative distinction — it is simply your cost basis.
Target Price
Current Price × (1 + Target Gain ÷ 100)
The price the agents project the stock could reach within the time window. This is your take-profit level — place a limit sell order here after buying.
e.g. $215.20 × 1.085 = $233.49 target on an 8.5% pick.
✓ Always above Current Price — this tool only selects upside candidates.
Target Gain
(Target Price − Current Price) ÷ Current Price × 100
The percentage return you would earn if the stock hits its Target Price from your entry. Set by the run parameters — every pick in this report targets the same percentage.
e.g. +8.5% means a $100 stock has a $108.50 target; a $500 stock has a $542.50 target.
✓ Always positive — picks are upside-only. A larger % means a bigger move is required.
Max Downside
Estimated stop-loss level, as % below entry
The worst-case loss the agents estimated if the thesis fails — based on key support levels and recent volatility. Use this as your hard stop-loss. If the price falls to this level, exit immediately; the trade thesis is broken.
e.g. −12.0% means: if you bought at $100, sell if it drops to $88.00.
⚠ Always negative. A smaller magnitude (e.g. −5%) = tighter risk. A larger magnitude (e.g. −20%) = more room to fall before you exit — riskier.
Reward : Risk
Target Gain ÷ |Max Downside|
How much you could gain for every dollar you are risking. A ratio of 2.0:1 means you stand to make $2 for every $1 at risk. Higher is better.
e.g. 8.5% gain ÷ 12% downside = 0.7:1 (unfavourable). 10% gain ÷ 5% downside = 2.0:1 (good).
✓ ≥ 2.0:1 is strong. ⚠ < 1.0:1 means you are risking more than you could gain — approach with caution.
Breakeven Win Rate
|Max Downside| ÷ (Target Gain + |Max Downside|) × 100
The minimum percentage of trades at this reward:risk that must succeed for you to break even over time — regardless of how good your stock picking is.
e.g. 12 ÷ (8.5 + 12) = 59% — you need roughly 6 in 10 trades to win just to avoid losing money.
✓ Lower is better — ≤ 35% means even a poor win rate is survivable. ⚠ ≥ 55% means you need most trades to work out.
Expected Value
(Probability% × Target Gain%) + ((1 − Probability%) × Max Downside%)
The average return per trade if the AI's probability estimate is accurate over many similar trades. A positive Expected Value means the trade has a mathematical edge; a negative value means the math works against you on average, even if you sometimes win.
e.g. 65% × +8.5% + 35% × −12% = +1.3% EV. Over 100 similar trades you would expect an average gain of 1.3% per trade.
✓ Positive = edge in your favour over many trades. ⚠ Negative = the math loses money on average — even if individual wins feel good. Note: EV is only as reliable as the probability estimate.
Suggested Allocation
half-Kelly: (Probability ÷ |Max Downside| − (1 − Probability) ÷ Target Gain) ÷ 2, capped at 10%
The Kelly criterion computes the portfolio fraction that maximises long-run growth for a bet with these odds; half-Kelly is the standard hedge against the probability estimate being too optimistic. Uses the calibrated probability where available. 0% means the math sees no edge worth sizing; — means it couldn't be computed.
e.g. 57% probability, +10% target, −13% downside → Kelly ≈ 8.5% of portfolio, half-Kelly ≈ 4.2%.
Generic sizing guidance only — not personal investment advice. Position sizing must reflect your own portfolio, risk tolerance and circumstances.
Every stock Scout considered — and why each was discarded

Scout scanned 503 S&P 500 constituents and short-listed 30 candidates for deep analysis by the five analysts. Here is what happened to each one.

  • WABWestinghouse Air Brake Technologies CorporationDropped at merge
    Scout: 13.5% 5-day surge on top of a 6.5% 30-day gain, now essentially at its 52-week high -- strong sustained momentum with no overhang.
    Qualified on merit but ranked #10, outside the 5-pick limit for this run.
  • TRVThe Travelers Companies, Inc.Dropped at merge
    Scout: Nearly 20% 30-day gain with a 13% 5-day pop, trading right at its 52-week high -- confirmed breakout momentum.
    Only Nova selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: Medium, 56% raw (60% after calibration)).
  • EIXEdison InternationalDropped at merge
    Scout: 11% 30-day return and 4.5% 5-day gain sitting essentially at its 52-week high, indicating a clean uptrend with room to extend.
    Only Quinn selected this stock — Quinn solo picks require High or Very High confidence and at least 60% probability (this pick: Medium, 60% raw (74% after calibration)).
  • WELLWelltower Inc.Dropped at merge
    Scout: 16% 30-day gain with continued 5-day follow-through, less than 1% from its 52-week high.
    Only Quinn selected this stock — Quinn solo picks require High or Very High confidence and at least 60% probability (this pick: Medium, 60% raw (74% after calibration)).
  • VTRVentas, Inc.Picked #1
    Scout: 17% 30-day and 5% 5-day gains just under its 52-week high -- healthcare REIT momentum broadly intact.
    Made the final report at #1.
  • TECHBio-Techne CorporationPassed over
    Scout: Nearly 29% 30-day gain while sitting within 1% of its 52-week high, showing the rally has legs rather than fading.
    Aria: 5-day momentum has flattened to just 0.66% and the MACD histogram has turned negative, suggesting the sharp 30-day rally is losing steam.
    Blaze: Latest quarter showed revenue and adjusted EPS actually declining year-over-year, a genuine fundamental negative despite the huge 30-day price rally
    Quinn: No qualifying quantitative setup — RSI is elevated (74.5) while the MACD histogram is negative, so momentum and overbought conditions conflict rather than confirm.
  • CTVACorteva, Inc.Not selected
    Scout: 11.6% 30-day gain with continued 5-day strength, essentially at its 52-week high.
    No analyst selected this candidate this run.
  • JPMJPMorgan Chase & Co.Dropped at merge
    Scout: Steady 5% 30-day gain within 1% of its 52-week high -- a large-cap bank leading the group without extended risk.
    Qualified on merit but ranked #7, outside the 5-pick limit for this run.
  • BACBank of America CorporationDropped at merge
    Scout: 7.7% 30-day gain trading right at its 52-week high, confirming bank-sector strength.
    Qualified on merit but ranked #8, outside the 5-pick limit for this run.
  • USBU.S. BancorpDropped at merge
    Scout: 9% 30-day gain within 1.3% of its 52-week high, extending the regional/large-bank rally.
    Qualified on merit but ranked #12, outside the 5-pick limit for this run.
  • MPCMarathon Petroleum CorporationPassed over
    Scout: Nearly 29% 30-day gain with continued 5-day strength, just 2.5% off its 52-week high on strong refining margins.
    Aria: RSI(14) of 78.7 is deeply overbought after a 28.9% one-month rally, making a pullback more likely than further near-term gains.
    Blaze: Despite a genuine earnings beat, the stock is extremely overbought (RSI near 79) after a 29% one-month rally, raising reversal risk ahead of earnings in under two weeks
    Nova: Momentum indicator is above 78, a level that flags an overbought, exhausted move despite the strong 30-day gain
    Orion: Extremely overbought (RSI 79) after a 29% one-month run, with earnings due in under two weeks adding reversal risk
  • VLOValero Energy CorporationPassed over
    Scout: 28% 30-day gain and 6.6% 5-day follow-through, close to its 52-week high alongside peer refiners.
    Nova: Similar setup to Phillips 66 but slightly weaker momentum confirmation; skipped in favor of PSX to avoid doubling up on the same refining sub-sector
    Orion: Similarly extended (RSI 72) after a 28% run and correlated with other refiner picks; earnings inside the window
    Quinn: Shares the same quantitative setup as our picks, but a wider ATR-based stop distance (-6.7%) gives it a less favorable risk/reward than the selected candidates.
  • PSXPhillips 66Dropped at merge
    Scout: 26% 30-day gain with an 8% 5-day pop, within 2% of its 52-week high -- refining sector momentum broadly confirmed.
    Only Nova selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: Medium, 56% raw (60% after calibration)).
  • TRGPTarga Resources Corp.Picked #2
    Scout: 7% 30-day gain sitting within 1% of its 52-week high, indicating steady midstream energy strength.
    Made the final report at #2.
  • CFCF Industries Holdings, Inc.Dropped at merge
    Scout: 22% 30-day gain with continued 7% 5-day upside on fertilizer/ag strength.
    Qualified on merit but ranked #13, outside the 5-pick limit for this run.
  • ADMArcher-Daniels-Midland CompanyDropped at merge
    Scout: 13% 30-day and 5% 5-day gains within 1.4% of its 52-week high.
    Qualified on merit but ranked #11, outside the 5-pick limit for this run.
  • METMetLife, Inc.Dropped at merge
    Scout: 6.8% 30-day gain within 1.5% of its 52-week high, confirming insurance-sector strength.
    Only Quinn selected this stock — Quinn solo picks require High or Very High confidence and at least 60% probability (this pick: Medium, 60% raw (74% after calibration)).
  • PRUPrudential Financial, Inc.Picked #3
    Scout: Nearly 10% 30-day gain with continued 5-day follow-through, close to its 52-week high.
    Made the final report at #3.
  • ALLThe Allstate CorporationNot selected
    Scout: 12.9% 30-day gain and a 4.9% 5-day pop, within 2.5% of its 52-week high.
    No analyst selected this candidate this run.
  • PCARPACCAR IncPassed over
    Scout: 8.3% 30-day gain with a strong 5.7% 5-day move, just over 1% from its 52-week high.
    Aria: A bearish volume divergence flag alongside an earnings report in 6 days adds too much near-term uncertainty.
    Blaze: Revenue declined year-over-year and the company narrowly missed earnings expectations, with a bearish volume divergence on the chart
    Quinn: OBV shows a bearish divergence, dragging the calculated probability down to the 50% floor — too weak a signal to include.
  • BBYBest Buy Co., Inc.Passed over
    Scout: Nearly 14% 30-day gain, within 1% of its 52-week high, showing durable consumer-discretionary demand.
    Blaze: The company's founder and chairman sold roughly $150 million of stock across several transactions in the last two months, an outsized insider selling signal
  • KIMKimco Realty CorporationDropped at merge
    Scout: 5.9% 30-day gain with continued 4.2% 5-day strength, just over 1% from its 52-week high.
    Only Quinn selected this stock — Quinn solo picks require High or Very High confidence and at least 60% probability (this pick: Medium, 60% raw (74% after calibration)).
  • FRTFederal Realty Investment TrustDropped at merge
    Scout: Consistent gains across both windows, trading within 1.1% of its 52-week high.
    Only Quinn selected this stock — Quinn solo picks require High or Very High confidence and at least 60% probability (this pick: Medium, 60% raw (74% after calibration)).
  • ABBVAbbVie Inc.Passed over
    Scout: 11.5% 30-day gain with a 5% 5-day pop, just 2% off its 52-week high -- pharma momentum intact.
    Aria: A bearish volume divergence flag and a negative MACD histogram offset otherwise decent momentum.
    Blaze: The company's most recent SEC filing actually lowered its quarterly adjusted EPS guidance due to acquisition-related charges, a negative signal
    Nova: Earnings in just over a week adds binary-event risk with no confirmed catalyst backing the current move
    Quinn: MACD histogram is negative and on-balance volume shows a bearish divergence, suggesting the price gain isn't fully backed by volume.
  • VTRSViatris Inc.Dropped at merge
    Scout: 12.6% 30-day gain and continued 3.9% 5-day strength, within 2% of its 52-week high.
    Qualified on merit but ranked #6, outside the 5-pick limit for this run.
  • INCYIncyte CorporationNot selected
    Scout: 13% 30-day gain within 2% of its 52-week high, showing sustained biotech strength.
    No analyst selected this candidate this run.
  • DOCHealthpeak Properties, Inc.Dropped at merge
    Scout: 11.4% 30-day gain with continued 5-day upside, close to its 52-week high.
    Qualified on merit but ranked #9, outside the 5-pick limit for this run.
  • MRKMerck & Co., Inc.Picked #5
    Scout: Nearly 11% 30-day gain with a 3.6% 5-day pop, within 3% of its 52-week high on defensive pharma demand.
    Made the final report at #5.
  • GDGeneral Dynamics CorporationPassed over
    Scout: 8.8% 30-day gain within 2% of its 52-week high, confirming defense-sector strength.
    Aria: Failed the momentum screen — 5-day price momentum was slightly negative (-0.43%) despite a positive 30-day trend.
    Quinn: MACD histogram is negative and 5-day momentum has turned negative (-0.4%), showing the uptrend losing steam.
  • CVSCVS Health CorporationPicked #4
    Scout: 8% 30-day and 3.3% 5-day gains, within 1.1% of its 52-week high.
    Made the final report at #4.

Agent Analytical Approaches

Aria

Momentum & Technical

Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.

Blaze

Fundamental & Earnings

Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).

Nova

News Catalyst & Event-Driven

Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.

Orion

Macro & Sector Rotation

Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.

Sage

Devil's Advocate

Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.

Quinn

Quantitative / Statistical

Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.